Literature DB >> 67306

Bromocriptine, gastric acid output, and gastrin secretion.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 67306

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine.

Authors:  P Sikiric; I Rotkvic; S Mise; M Petek; R Rucman; S Seiwerth; V Zjacic-Rotkvic; M Duvnjak; V Jagic; E Suchanek
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  Effect of L-dopa with and without inhibition of extra cerebral dopa decarboxylase on gastric acid secretion and gastrin release in man.

Authors:  R Caldara; C Barbieri; V Piepoli; M Borzio; E Masci
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

3.  Effect of dopamine infusion on gastric and pancreatic secretion and on gastrin release in man.

Authors:  R Caldara; C Ferrari; M Romussi; L Bierti; S Gandini; G Curtarelli
Journal:  Gut       Date:  1978-08       Impact factor: 23.059

Review 4.  Pharmacology of bromocriptine in health and disease.

Authors:  A E Mehta; G Tolis
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

5.  Failure of oral bromocriptine to affect hypergastrinemia in two patients with the Zollinger-Ellison syndrome.

Authors:  D F Child; I Laing; P C Ganguli
Journal:  J Endocrinol Invest       Date:  1978-10       Impact factor: 4.256

6.  Effect of bromocriptine administration on gastric acid and gastrin secretion in man.

Authors:  R Caldara; C Ferrari; M Romussi; A Paracchi
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.